| Alternative Name: | Fibroblast growth factor 9, Glia activating factor, GAF, Heparin-binding growth factor-9, HBGF-9 |
| |
| MW: | ~23.4 kDa |
| |
| Source: | Produced in E. coli. Contains 207 amino acids. |
| |
| UniProt ID: | P54130 |
| |
| Formulation: | Lyophilized from a sterile (0.2 micron) filtered solution containing 10 mM sodium phosphate, pH 7.5. |
| |
| Purity: | ≥95% (SDS-PAGE) |
| |
| Endotoxin Content: | ≤1 EU/µg protein (LAL test) |
| |
| Reconstitution: | Reconstitute in sterile water at 0.1 mg/mL. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -80°C |
| |
| Handling: | Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -80°C. For long term storage, it is recommended to dilute to working aliquots in a 0.1% BSA solution. |
| |
| Scientific Background: | Fibroblast growth factor 9 (FGF-9) is a mitogen and survival factor for nerve and mesenchymal cells. FGF-9 functions as an autocrine and paracrine factor to support the growth and survival of motor neurons and prostate tissue and is also necessary for sex determination. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
